Retrospective study of treatment with a drug-coated balloon alone is beneficial for ostial coronary lesions.

ABSTRACT:

Background

The effects of ostial coronary lesion (OCL) treatment with a drug-coated balloon (DCB) alone remain controversial. This retrospective study assessed the effectiveness and safety with DCB only strategy for OCL and the factors associated with target lesion revascularization (TLR) in these patients.

Methods

The study retrospectively included patients whom had OCLs treated with a paclitaxel-eluting DCB only strategy from 1 May 2014 to 1 May 2017. Patients were divided into in-stent restenosis (ISR) and de novo (primary) groups. And all patients came back to hospital, and underwent clinical and also angiographic follow-up.

Results

Among the 44 patients with 55 OCLs, 12 (27.3%) were assigned to the ISR group and 32 (72.7%) to the de novo group. The

SUBMITTER: Zhang W 

PROVIDER: S-EPMC9096279 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature